Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | KLK7 | P49862 | 1/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6522180 | 0.94 | NLRP3 (0.41) | HCAR2ALDH1A1SMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL6521140 | 0.88 | KMT2A (0.40) | HCAR2ALDH1A1SMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL6518113 | 0.86 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1GAAMAPTKMT2A | |
| SCHEMBL8812407 | 0.84 | HCAR2 (0.46) | HCAR2ALDH1A1MAPTKDM4EKMT2A | |
| SCHEMBL7039893 | 0.82 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2L3MBTL1GAAMAPT | |
| SCHEMBL6522589 | 0.81 | TSHR (0.38) | SMN1; SMN2L3MBTL1KDM4ELMNAPOLB | |
| SCHEMBL6514718 | 0.78 | HCAR2 (0.41) | HCAR2MAPTKDM4EKMT2AKLK7 | |
| SCHEMBL10762397 | 0.77 | HCAR2 (0.47) | HCAR2ALDH1A1MAPTKDM4EKMT2A | |
| SCHEMBL6520877 | 0.76 | MMP8 (0.41) | ALDH1A1SMN1; SMN2MAPTKMT2ALMNA | |
| SCHEMBL3883004 | 0.76 | HCAR2 (0.56) | HCAR2ALDH1A1MAPTKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | HCAR2 3143/4885ALDH1A1 1254/4885SMN1; SMN2 1768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.